Next Science (ASX:NXS) FCF Yield % : -30.77 (As of Jun. 07, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Next Science FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Next Science's Trailing 12-Month Free Cash Flow is A$-23.79 Mil, and Market Cap is A$77.30 Mil. Therefore, Next Science's FCF Yield % for today is -30.77%.

The historical rank and industry rank for Next Science's FCF Yield % or its related term are showing as below:

ASX:NXS' s FCF Yield % Range Over the Past 10 Years
Min: -42.13 Med: -8.53 Max: -4.53
Current: -30.77

During the past 6 years, the highest FCF Yield % of Next Science was -4.53%. The lowest was -42.13%. And the median was -8.53%.

ASX:NXS's FCF Yield % is ranked worse than
87.79% of 1081 companies
in the Drug Manufacturers industry
Industry Median: -0.16 vs ASX:NXS: -30.77

Next Science's FCF Margin % for the quarter that ended in Dec. 2023 was -63.07%.

Next Science FCF Yield % Historical Data

The historical data trend for Next Science's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science FCF Yield % Chart

Next Science Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-5.98

-6.89

-5.09

-12.35

-24.02

Next Science Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial					-6.23	-11.96	-11.62	-19.93	-22.93

Competitive Comparison of Next Science's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Next Science's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Next Science's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Next Science's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Next Science's FCF Yield % falls into.

Next Science FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Next Science's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-23.819	/	99.1763
	=	-24.02%

Next Science's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-11.371	*	2	/	99.1763
	=	-22.93%

Next Science FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Next Science FCF Yield % Related Terms

Thank you for viewing the detailed overview of Next Science's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Next Science (ASX:NXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

NXSCF:USA

Address

821 Pacific Highway, Suite 1902, Level 19, Tower A, The Zenith Building, Chatswood, NSW, AUS, 2067

Website

https://www.nextscience.com

Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from the U.S. and Australia, of which prime revenue is derived from the U.S.

Next Science (ASX:NXS) Headlines

No Headlines